Trademark: 79230282
Word
PROCAN
Status
Registered
Status Code
700
Status Date
Tuesday, December 25, 2018
Serial Number
79230282
Registration Number
5635196
Registration Date
Tuesday, December 25, 2018
Mark Type
3000
Filing Date
Wednesday, March 22, 2017
Published for Opposition
Tuesday, October 9, 2018

Trademark Owner History

Classifications
41 Education services, namely, mentoring, tutoring, classes, seminars, and workshops in the fields of medical, proteomic, molecular and genetic analysis and testing and medical research and development; Training services in the fields of medical, proteomic, molecular and genetic analysis and testing and medical research and development; Publishing of electronic publications; Publishing of books, documents, newsletters, and printed matter in the fields of medical diagnosis, medical treatment, medical, proteomic, molecular and genetic analysis and testing, and medical research and development; Advisory, consultancy, and information services in the fields of education and publishing
9 Software and computer programs for use in medical, proteomic, molecular and genetic analysis and testing; Computer hardware for use in medical, proteomic, molecular and genetic analysis and testing; Scientific apparatus, namely, mass-spectrometers; Downloadable databases in the fields of medicine, proteomics, molecules and genetics; Electronic publications, both downloadable and recorded on computer media, namely, magazines, journals, newspapers, manuals, and e-books in the fields of medicine, proteomics, molecules and genetics
16 Printed matter, namely, printed publications, namely, journals, leaflets, pamphlets, booklets, and research reports in the fields of medical research and development services, genetics, molecules and proteomics
36 Charitable fundraising; Financial services, namely, funding research in the fields of medical research, genetic research, molecular research and proteomic research; Fundraising services, by means of raising funds for scientific research, proteomic research, molecular research, genetic research and medical research; Financial sponsorship of medical research, genetic research, molecular research and proteomic research; Funding of scientific and medical research; Fundraising services by means of organizing special events to support medical research, proteomic research, molecular research and genetic research; Advisory, consultancy, and information services in the fields of fundraising and financial sponsorship for medical research, proteomic research, molecular research and genetic research
44 Medical services, namely, medical health assessment services; Medical services, namely, genetic, proteomic and molecular screening and testing for medical purposes; Medical services, namely, testing physical tumors; Health care services, namely, medical treatment of cancer, health care diagnosis of diseases services, health assessment services, testing of physical tumors, and genetic, proteomic, and molecular screening and testing; Health screening services in the field of oncology testing, proteomic testing, molecular testing and genetic testing; Health risk assessment surveys; Arranging of medical treatment; Conducting of medical examinations; Genetic testing for medical purposes; Advisory, consultancy and information services in the fields of medicine and healthcare
42 Research, namely, medical research, proteomic research, molecular research and genetic research; Scientific and technological services, namely, scientific research and analysis in the field of medicine medical diagnosis, medical treatment, proteomics, biology, biotechnology and genetics; Analysis of tissues for medical research; Research laboratories; Biological research; Biotechnology research; Genetic research; Development of testing methods and testing methodologies in the fields of medical research, proteomic research, molecular research and genetic research; Development of test equipment for medical research; Technical research in the fields of medicine, proteomics, biology, biotechnology, and genetics; Database design; Scientific research relating to genetics; Advisory, consultancy, and information services in the fields of medical research, scientific research, proteomic research, molecular research and genetic research
The mark consists of the stylized wording "PROCAN" with an image, to the left of the wording, of ribbon folded to make a loop with the end curled and breaking into small squares and rectangles.
PRO CAN
Color is not claimed as a feature of the mark.

Trademark Events
Dec 25, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jun 28, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 28, 2022
Teas Change Of Correspondence Received
Jun 28, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 28, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 28, 2022
Teas Change Of Owner Address Received
Jun 22, 2022
Withdrawal Of Attorney Granted
Jun 22, 2022
Teas Withdrawal Of Attorney Received
May 26, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
May 26, 2022
Teas Change Of Correspondence Received
May 26, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
May 26, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 26, 2022
Teas Change Of Owner Address Received
Apr 26, 2019
Final Decision Transaction Processed By Ib
Apr 10, 2019
Final Disposition Notice Sent To Ib
Apr 10, 2019
Final Disposition Processed
Mar 25, 2019
Final Disposition Notice Created, To Be Sent To Ib
Dec 25, 2018
Registered-Principal Register
Oct 9, 2018
Official Gazette Publication Confirmation E-Mailed
Oct 9, 2018
Published For Opposition
Oct 6, 2018
Notification Processed By Ib
Sep 19, 2018
Notification Of Possible Opposition Sent To Ib
Sep 19, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 19, 2018
Notification Of Notice Of Publication E-Mailed
Sep 4, 2018
Assigned To Lie
Aug 21, 2018
Approved For Pub - Principal Register
Aug 21, 2018
Examiner's Amendment Entered
Aug 21, 2018
Notification Of Examiners Amendment E-Mailed
Aug 21, 2018
Examiners Amendment E-Mailed
Aug 21, 2018
Examiners Amendment -Written
Aug 18, 2018
Notification Of Priority Action E-Mailed
Aug 18, 2018
Priority Action E-Mailed
Aug 18, 2018
Priority Action Written
Jul 28, 2018
Teas/Email Correspondence Entered
Jul 27, 2018
Correspondence Received In Law Office
Jul 27, 2018
Teas Response To Office Action Received
May 12, 2018
Refusal Processed By Ib
Apr 23, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Apr 23, 2018
Refusal Processed By Mpu
Apr 20, 2018
Application Filing Receipt Mailed
Apr 19, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Apr 18, 2018
Non-Final Action Written
Apr 16, 2018
Assigned To Examiner
Apr 16, 2018
New Application Office Supplied Data Entered
Apr 12, 2018
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24